Precision Optics Inc 's ROA from the fourth quarter of 2026 to the fourth quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Precision Optics Inc 's ROA in the fourth quarter of 2026?
Precision Optics Corporation Inc recorded a cumulative net loss of $-4 million during 12 months ending in the fourth quarter of 2026, resulting in a negative return on assets (ROA) of -12.19%.

However, within the Healthcare sector 325 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Jun 30 2026 quarter, so far to 3464, from total ROA ranking in the third quarter of 2026 at 4344.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Jun 30 2026) IV. Quarter	(Mar 31 2026) III. Quarter	(Dec 31 2025) II. Quarter	(Sep 30 2025) I. Quarter	(Jun 30 2025) IV. Quarter
Y / Y Total Assets Change	118.56 %	71.67 %	17.01 %	29.85 %	17.01 %
Y / Y Net Income Change	-	-	-	-	-
Net Income (TTM) in million	-4	-5	-7	-6	-6
Return On Assets (TTM)	-12.19 %	-20.61 %	-33.91 %	-31.03 %	-31.43 %
POCI's Total Ranking	# 3464	# 4344	# 3790	# 3819	# 3895
Total Assets (TTM) in million	43	34	20	22	20
Seq. Total Assets Change	28.4 %	70.22 %	-11.59 %	13.11 %	0.86 %
Seq. Net Income Change	-	-	-	-	-

POCI's 5 Years Annual ROA >> Back to POCI Management Effectiveness >> Compare POCI ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 103
Sector	# 326
Overall	# 3287

Return On Assets Statistics
High	Average	Low
183.18 %	-21.47 %	-104.36 %
(Jun 30 2012)		(Sep 30 2013)

Financial Statements
Precision Optics Inc 's Assets	$ 43 million	POCI's Balance sheet
Precision Optics Inc 's Income	$ 0 million	Quarterly POCI's Income Statement
POCI's Income by Division		See POCI's Income by Division

Annual Return On Assets	(Jun 30 2026) FY 2026	(Jun 30 2025) FY 2025	(Jun 30 2024) FY 2024	(Jun 30 2023) FY 2023	(Jun 30 2022) FY 2022
Y / Y Total Assets Change	118.56 %	17.01 %	-14.32 %	18.18 %	166.78 %
Total Assets in million	43	20	17	20	17
Y / Y Net Income Change	-	-	-	-	-
Net Income in million	-4	-6	-3	0	-1
Annual Return On Assets	-8.39 %	-29.21 %	-17.45 %	-0.73 %	-5.56 %

POCI's 5 Years Annual ROA >> Back to POCI Management Effectiveness >> Compare POCI ROA to its Competitors

More Return On Assets Ratios
POCI's' Return on Assets at Yahoo Finance
Medical Equipment & Supplies Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
POCI's Roa Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for POCI's Competitors
Subscribers only: Roa for Precision Optics Inc 's Suppliers
Subscribers only: Return On Assets for POCI's Customers

You may also want to know
POCI's Roi	POCI's Inventory Turnover Ratio	POCI's Growth Rates	POCI's Dividend Comparisons
	POCI's Profitability Ratios	POCI's Asset Turnover Ratio	POCI's Dividend Growth
POCI's Roe	POCI's Valuation Ratios	POCI's Financial Strength Ratios	POCI's Dividend Payout Ratio

Companies with similar Return On Assets at Jun 30 2026, within Healthcare Sector

ROA

Date modified: 2026-09-29T04:38:44+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.